日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation

用于 COVID-19 疫苗设计和验证的高度保守、非人类样和交叉反应的 SARS-CoV-2 T 细胞表位

Lauren M Meyers, Andres H Gutiérrez, Christine M Boyle, Frances Terry, Bethany G McGonnigal, Andres Salazar, Michael F Princiotta, Wiliam D Martin, Anne S De Groot, Leonard Moise

Development of highly stable and de-immunized versions of recombinant alpha interferon: Promising candidates for the treatment of chronic and emerging viral diseases

开发高度稳定和去免疫版本的重组干扰素α:治疗慢性和新兴病毒性疾病的有希望的候选药物

Sofía Inés Giorgetti, Marina Etcheverrigaray, Frances Terry, William Martin, Anne Searls De Groot, Natalia Ceaglio, Marcos Oggero, Eduardo Federico Mufarrege

Preclinical development of HIvax: Human survivin highly immunogenic vaccines

HIvax 的临床前开发:人类 survivin 高免疫原性疫苗

Peter R Hoffmann, Maddalena Panigada, Elisa Soprana, Frances Terry, Ivo Sah Bandar, Andrea Napolitano, Aaron H Rose, Fukun W Hoffmann, Lishomwa C Ndhlovu, Mahdi Belcaid, Lenny Moise, Anne S De Groot, Michele Carbone, Giovanni Gaudino, Takashi Matsui, Antonio Siccardi, Pietro Bertino

Dendritic cell-mediated, DNA-based vaccination against hepatitis C induces the multi-epitope-specific response of humanized, HLA transgenic mice

树突状细胞介导的基于 DNA 的丙型肝炎疫苗接种可诱导人源化 HLA 转基因小鼠的多表位特异性反应

Sasmita Mishra, Bianca J Lavelle, Joe Desrosiers, Matt T Ardito, Frances Terry, William D Martin, Anne S De Groot, Stephen H Gregory